Premacure
Uppsala
About Premacure
Premacure develops and commercializes insulin-like growth factor I (IGF-I) for unmet medical needs for the neonate. It develops IGF-I together with or without its IGFBP-3 natural binding protein for the prevention of complications of preterm birth.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: premacure.com
- Phone: +46 7 06 50 28 52
Canonical: https://fsome.com/organization/premacure-2294628 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.